Cargando…
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Adoptive transfer of large numbers of tumor-reactive CD8(+) cytotoxic T lymphocytes (CTLs) expanded and differentiated in vitro has shown promising clinical activity against cancer. However, such protocols are complicated by extensive ex vivo manipulations of tumor-reactive cells and have largely fo...
Autores principales: | Quezada, Sergio A., Simpson, Tyler R., Peggs, Karl S., Merghoub, Taha, Vider, Jelena, Fan, Xiaozhou, Blasberg, Ronald, Yagita, Hideo, Muranski, Pawel, Antony, Paul A., Restifo, Nicholas P., Allison, James P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839156/ https://www.ncbi.nlm.nih.gov/pubmed/20156971 http://dx.doi.org/10.1084/jem.20091918 |
Ejemplares similares
-
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma
por: Xie, Ying, et al.
Publicado: (2010) -
RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION
por: Bazin, Renee, et al.
Publicado: (2023) -
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
por: Kroemer, Alexander, et al.
Publicado: (2020) -
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
por: Quezada, Sergio A., et al.
Publicado: (2008) -
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
por: Bermejo-Martin, Jesús F, et al.
Publicado: (2020)